Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Jean

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Nephrologie & Therapeutique|January 26, 2016
[Improving secondary hyperparathyroidism treatment in Maghreb to get rid of brown tumors]Guillaume Jean
Nephrologie & Therapeutique|July 19, 2014
[Another story of sevelamer]Guillaume Jean
Presse Medicale (Paris, France : 1983)|September 3, 2011
[How to manage mineral metabolism disorders in renal failure]Guillaume Jean
Nephrologie & Therapeutique|May 29, 2019
[Complications and treatment of mineral and bone disorders in chronic kidney disease]Guillaume Jean, Charles Chazot
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2011
Phosphate binders in a European haemodialysis populationGuillaume Jean, Thierry Vanel
Nephron. Clinical Practice|April 24, 2010
Intradialytic hypertension: it is time to actCharles Chazot, Guillaume Jean
Blood Purification|December 6, 2018
End-Stage Kidney Patients Require Hemodialysis Therapy Full StartCharles Chazot, Guillaume Jean
Current Opinion in Nephrology and Hypertension|September 16, 2015
Individualizing the dialysate calcium concentrationGuillaume Jean, Charles Chazot
Nature Clinical Practice. Nephrology|November 26, 2008
The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessionsCharles Chazot, Guillaume Jean
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2013
Sclerostin in CKD-MBD: one more paradoxical bone protein?Guillaume Jean, Charles Chazot
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Nephrologie & Therapeutique|January 26, 2016
[Improving secondary hyperparathyroidism treatment in Maghreb to get rid of brown tumors]Guillaume Jean
Nephrologie & Therapeutique|July 19, 2014
[Another story of sevelamer]Guillaume Jean
Presse Medicale (Paris, France : 1983)|September 3, 2011
[How to manage mineral metabolism disorders in renal failure]Guillaume Jean
Nephrologie & Therapeutique|May 29, 2019
[Complications and treatment of mineral and bone disorders in chronic kidney disease]Guillaume Jean, Charles Chazot
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2011
Phosphate binders in a European haemodialysis populationGuillaume Jean, Thierry Vanel
Nephron. Clinical Practice|April 24, 2010
Intradialytic hypertension: it is time to actCharles Chazot, Guillaume Jean
Blood Purification|December 6, 2018
End-Stage Kidney Patients Require Hemodialysis Therapy Full StartCharles Chazot, Guillaume Jean
Current Opinion in Nephrology and Hypertension|September 16, 2015
Individualizing the dialysate calcium concentrationGuillaume Jean, Charles Chazot
Nature Clinical Practice. Nephrology|November 26, 2008
The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessionsCharles Chazot, Guillaume Jean
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2013
Sclerostin in CKD-MBD: one more paradoxical bone protein?Guillaume Jean, Charles Chazot
Pageof 13